Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Safety Considerations and Contraindications Who Should Avoid CJC-1295 Ipamorelin Contraindications : Active cancer diagnosis (growth hormone can stimulate existing tumors) Pregnancy or breastfeeding Severe cardiovascular disease Uncontrolled diabetes Children and adolescents under 18 Potential Drug Interactions CJC-1295 Ipamorelin may interact with: Insulin and diabetes medications (can affect blood sugar) Corticosteroids (may blunt GH response) Thyroid medications (may require dose adjustments) Other hormone therapies Medical Supervision Requirements Consult healthcare providers before starting if you have: Diabetes or blood sugar issues Cardiovascular conditions History of cancer Current prescription medications Sleep disorders Our Clinics Experience with CJC-1295 Ipamorelin Dosing Through extensive clinical experience with CJC-1295 Ipamorelin protocols, weve observed optimal results with 200 mcg of each peptide administered before bed, 5 days per week
Your provider will guide you on safe next steps if you decide to pause or discontinue treatment
It may increase IGF-1, so monitoring is essential
The panel's recommendations are non-binding but they carry significant weight with the FDA
And while some companies, such as Lilly, are testing their analogs as stand-alone therapies, others, including Novo Nordisk, are combining them with GLP-1s
US$ 25.88
US$ 22.58
US$ 22.24
